Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Nat Rev Drug Discov. 2016 Dec 23;16(2):89–100. doi: 10.1038/nrd.2016.238

Table 1.

Comparison of screening platforms

Characteristic CRISPRn CRISPRi RNAi (miRNA-based shRNAs) CRISPRa
Effect Knockout (KO) Knockdown (KD) Knockdown (KD) Activation
Mechanism Indel, mutation Transcriptional interference Transcript degradation, translational interference Transcriptional activation
Guide target choice Anywhere in the genome (PAM) Transcription start site (TSS; PAM) Exons Transcription start site (TSS; PAM)
Target selectivity Can distinguish any target Depends on TSS, cannot distinguish products derived from the same transcript Can distinguish splice variants Depends on TSS, cannot distinguish products derived from the same transcript
Highly amplified regions (genes) Off-target effects: DSBs evoke DNA damage repair, resulting in cell cycle arrest independent of target Can be targeted if all use the same TSS Can be targeted Can be targeted if all use the same TSS
Distinguish alternative TSSs Possible Yes Possible Yes
Distinguish transcript splice variants Possible No Possible No
Performance of individual sgRNAs or shRNAs Most work Many work Requires good prediction tools or testing Many work